These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28733355)

  • 1. ERK/MAPK Signaling Is Required for Pathway-Specific Striatal Motor Functions.
    Hutton SR; Otis JM; Kim EM; Lamsal Y; Stuber GD; Snider WD
    J Neurosci; 2017 Aug; 37(34):8102-8115. PubMed ID: 28733355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
    Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
    J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Manipulation of G-Protein γ
    Brunori G; Pelletier OB; Stauffer AM; Robishaw JD
    J Neurosci; 2021 Nov; 41(44):9065-9081. PubMed ID: 34544837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatopallidal Neuron NMDA Receptors Control Synaptic Connectivity, Locomotor, and Goal-Directed Behaviors.
    Lambot L; Chaves Rodriguez E; Houtteman D; Li Y; Schiffmann SN; Gall D; de Kerchove d'Exaerde A
    J Neurosci; 2016 May; 36(18):4976-92. PubMed ID: 27147651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR88 in D1R-Type and D2R-Type Medium Spiny Neurons Differentially Regulates Affective and Motor Behavior.
    Meirsman AC; Ben Hamida S; Clarke E; de Kerchove d'Exaerde A; Darcq E; Kieffer BL
    eNeuro; 2019; 6(4):. PubMed ID: 31346000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPRIN3 Controls Neuronal Excitability, Morphology, and Striatal-Dependent Behaviors in the Indirect Pathway of the Striatum.
    Karadurmus D; Rial D; De Backer JF; Communi D; de Kerchove d'Exaerde A; Schiffmann SN
    J Neurosci; 2019 Sep; 39(38):7513-7528. PubMed ID: 31363062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Toy WA; Petzinger GM; Leyshon BJ; Akopian GK; Walsh JP; Hoffman MV; Vučković MG; Jakowec MW
    Neurobiol Dis; 2014 Mar; 63():201-9. PubMed ID: 24316165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocytosis following dopamine D
    Shioda N; Yabuki Y; Wang Y; Uchigashima M; Hikida T; Sasaoka T; Mori H; Watanabe M; Sasahara M; Fukunaga K
    Mol Psychiatry; 2017 Aug; 22(8):1205-1222. PubMed ID: 27922607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
    Cerovic M; Bagetta V; Pendolino V; Ghiglieri V; Fasano S; Morella I; Hardingham N; Heuer A; Papale A; Marchisella F; Giampà C; Calabresi P; Picconi B; Brambilla R
    Biol Psychiatry; 2015 Jan; 77(2):106-15. PubMed ID: 24844602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum.
    Gangarossa G; Perroy J; Valjent E
    Brain Struct Funct; 2013 Mar; 218(2):405-19. PubMed ID: 22453353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF1-cAMP signaling dissociates cell type-specific contributions of striatal medium spiny neurons to reward valuation and motor control.
    Sutton LP; Muntean BS; Ostrovskaya O; Zucca S; Dao M; Orlandi C; Song C; Xie K; Martemyanov KA
    PLoS Biol; 2019 Oct; 17(10):e3000477. PubMed ID: 31600280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors.
    Fasano C; Bourque MJ; Lapointe G; Leo D; Thibault D; Haber M; Kortleven C; Desgroseillers L; Murai KK; Trudeau LÉ
    Neuropharmacology; 2013 Apr; 67():432-43. PubMed ID: 23231809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting patterns of ERK activation in the tail of the striatum in response to aversive and rewarding signals.
    Gangarossa G; Castell L; Castro L; Tarot P; Veyrunes F; Vincent P; Bertaso F; Valjent E
    J Neurochem; 2019 Oct; 151(2):204-226. PubMed ID: 31245856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 receptors in striatal output neurons enable the psychomotor effects of cocaine.
    Kharkwal G; Radl D; Lewis R; Borrelli E
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11609-11614. PubMed ID: 27671625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRMP2 mediates GSK3β actions in the striatum on regulating neuronal structure and mania-like behavior.
    Kim W; Won SY; Yoon BJ
    J Affect Disord; 2019 Feb; 245():1079-1088. PubMed ID: 30699850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors.
    Ruiz-Calvo A; Maroto IB; Bajo-Grañeras R; Chiarlone A; Gaudioso Á; Ferrero JJ; Resel E; Sánchez-Prieto J; Rodríguez-Navarro JA; Marsicano G; Galve-Roperh I; Bellocchio L; Guzmán M
    Cereb Cortex; 2018 Jan; 28(1):307-322. PubMed ID: 29121220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal functions.
    Révy D; Jaouen F; Salin P; Melon C; Chabbert D; Tafi E; Concetta L; Langa F; Amalric M; Kerkerian-Le Goff L; Marie H; Beurrier C
    Neuropsychopharmacology; 2014 Oct; 39(11):2662-72. PubMed ID: 24903652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
    Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R
    Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.